These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19754418)

  • 21. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX.
    Elkady M; Nieß R; Schaible AM; Bauer J; Luderer S; Ambrosi G; Werz O; Laufer SA
    J Med Chem; 2012 Oct; 55(20):8958-62. PubMed ID: 22992107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cyclooxygenase-1/-2, microsomal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory mediators by PGE(2) in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells.
    Li P; Lu J; Kaur C; Sivakumar V; Tan KL; Ling EA
    Neuroscience; 2009 Dec; 164(3):948-62. PubMed ID: 19712723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural products as inhibitors of prostaglandin E
    Koeberle A; Werz O
    Biotechnol Adv; 2018 Nov; 36(6):1709-1723. PubMed ID: 29454981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment.
    Larsson K; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():161-5. PubMed ID: 26100239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E(2) synthase inhibition as a therapeutic target.
    Iyer JP; Srivastava PK; Dev R; Dastidar SG; Ray A
    Expert Opin Ther Targets; 2009 Jul; 13(7):849-65. PubMed ID: 19530988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.
    Bahia MS; Katare YK; Silakari O; Vyas B; Silakari P
    Med Res Rev; 2014 Jul; 34(4):825-55. PubMed ID: 25019142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E(2) synthase-1 inhibitors.
    Banerjee A; Pawar MY; Patil S; Yadav PS; Kadam PA; Kattige VG; Deshpande DS; Pednekar PV; Pisat MK; Gharat LA
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4838-44. PubMed ID: 25260492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of anti-inflammatory drugs targeted against prostaglandin-related molecules].
    Sato T; Nakajima T; Yamano Y
    Nihon Rinsho; 2010 Oct; 68(10):1835-9. PubMed ID: 20954326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Bauer J; Verhoff M; Hoffmann M; Northoff H; Werz O
    Biochem Biophys Res Commun; 2009 Oct; 388(2):350-4. PubMed ID: 19665000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2).
    Yamada T; Komoto J; Watanabe K; Ohmiya Y; Takusagawa F
    J Mol Biol; 2005 May; 348(5):1163-76. PubMed ID: 15854652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
    Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
    J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice.
    Isono M; Suzuki T; Hosono K; Hayashi I; Sakagami H; Uematsu S; Akira S; DeClerck YA; Okamoto H; Majima M
    Life Sci; 2011 Apr; 88(15-16):693-700. PubMed ID: 21324324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
    Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
    Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular biology of microsomal prostaglandin E synthase-1.
    Wang M; FitzGerald GA
    Trends Cardiovasc Med; 2010 Aug; 20(6):189-95. PubMed ID: 22137640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
    Wang M; Song WL; Cheng Y; Fitzgerald GA
    J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
    Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
    Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.
    Cipollone F; Fazia M; Iezzi A; Zucchelli M; Pini B; De Cesare D; Ucchino S; Spigonardo F; Bajocchi G; Bei R; Muraro R; Artese L; Piattelli A; Chiarelli F; Cuccurullo F; Mezzetti A
    Circulation; 2003 Mar; 107(11):1479-85. PubMed ID: 12654603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness.
    Wang M; Cooper PR; Jiang M; Zhao H; Hui Y; Yao Y; Tate JC; Damera G; Lawson JA; Jester WF; Haczku A; Panettieri RA; FitzGerald GA
    J Pharmacol Exp Ther; 2010 Jul; 334(1):63-8. PubMed ID: 20371706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.